Transdermal Skin Patches Market
Transdermal Skin Patches Market Forecasts to 2030 - Global Analysis By Component (Reservoir, Drug-in-Adhesive and Other Components), By Application (Pain Management, Cardiovascular Disorders, Central Nervous System Disorders and Other Applications), Distribution Channel and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $8.2 BN |
|
Projected Year Value (2030) |
US $12.8 BN |
|
CAGR (2023-2030) |
6.6% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Transdermal Skin Patches Market is accounted for $8.2 billion in 2023 and is expected to reach $12.8 billion by 2030 growing at a CAGR of 6.6% during the forecast period. Transdermal skin patches are medical devices designed to deliver medication through the skin and into the bloodstream. Comprising layers including an adhesive, drug reservoir and a controlling membrane, these patches offer controlled, continuous drug release. They adhere to the skin, allowing drugs to be absorbed directly into circulation, bypassing the digestive system. They provide a convenient, non-invasive delivery method for various medications, maintaining steady therapeutic levels over time.
According to the GLOBOCAN 2020 report, 195,499 cancer cases were reported in Mexico in 2020, with breast and prostate cancers being the most common among the population.
Market Dynamics:
Driver:
Increasing advantages over the oral and ingesting medications
The rising preference for transdermal skin patches is fueled by their distinct advantages over oral medication. These patches offer non-invasive drug delivery, bypassing the digestive system and reducing gastrointestinal side effects. They ensure a steady, controlled release of medication, maintain consistent therapeutic levels and enhance patient compliance. With fewer dosing frequencies and simplified application, they provide convenience, especially for long-term therapies. Additionally, transdermal patches mitigate issues related to drug degradation in the digestive tract, improving bioavailability and offering a promising alternative to traditional oral medications.
Restraint:
Lack of awareness and elevated product costs
The limited awareness surrounding transdermal skin patches and their higher product costs pose significant restraints. Insufficient knowledge among consumers and healthcare professionals about their benefits and applications may limit their adoption. Moreover, elevated production expenses involved in formulating and manufacturing these patches contribute to higher market prices, impacting accessibility for some patients. These combined factors hinder widespread acceptance and affordability, impeding the potential utilization of this effective drug delivery system for various medical conditions.
Opportunity:
Growing need for prescription transdermal patches
The increasing demand for prescription transdermal patches presents a significant opportunity in the transdermal skin patch market. This surge reflects evolving preferences for non-oral drug delivery methods and a growing emphasis on patient convenience. With a shift toward personalized medicine and targeted therapies, the need for specialized, prescription-based patches is rising. It also fuels research into enhanced patch technologies, expanding treatment options and driving market growth in the transdermal medication sector.
Threat:
Skin's limited capacity to absorb various active substances?
The skin's selective permeability poses a challenge for transdermal patches, as not all substances can effectively penetrate its barriers. This limitation restricts the range of medications suitable for transdermal delivery, hindering the development of certain therapies. Additionally, large molecules, hydrophilic compounds and those with specific chemical properties struggle to traverse the skin barrier effectively, limiting the range of substances suitable for transdermal delivery.
Covid-19 Impact:
The COVID-19 pandemic has significantly influenced the transdermal skin patches market. While demand for certain patches, like those delivering pain relief or hormone therapies, remained steady, disruptions in supply chains and healthcare access impacted production and distribution. Lockdowns also affected patient consultations, potentially hindering new prescriptions and routine check-ups for patch users. However, the pandemic underscored the significance of non-invasive drug delivery methods, potentially driving further innovation and adoption of transdermal patches in the future.
The drug-in-adhesive segment is expected to be the largest during the forecast period
The drug-in-adhesive segment is expected to dominate the market during the forecast period due to its advantages. Drug-in-adhesive patches integrate the drug directly into the adhesive layer, ensuring precise dosing and enhanced skin contact. This design offers convenience, simplicity in application, and consistent drug delivery. Moreover, it minimizes the risk of accidental detachment. With its user-friendly application and reliable drug release profile, the drug-in-adhesive patch is anticipated to remain the preferred choice, fostering its prominence in the market.
The hospital pharmacies segment is expected to have the highest CAGR during the forecast period
The hospital pharmacies segment is poised for significant growth due to various factors. Hospitals play a pivotal role in patient care and are key distribution points for pharmaceuticals, including transdermal patches. The increasing prevalence of chronic diseases requiring long-term medication, coupled with the rising adoption of transdermal drug delivery systems, is driving demand in hospital pharmacies. Additionally, the convenience of obtaining and administering patches within a hospital setting contributes to the projected substantial growth of the market.
Region with largest share:
North America is anticipated to lead the transdermal skin patches market due to its advanced healthcare infrastructure, high healthcare expenditure and robust focus on technological advancements in drug delivery systems. Additionally, a growing elderly population with chronic conditions, coupled with the prevalence of lifestyle-related diseases, fuels the demand for transdermal patches. Moreover, supportive regulatory frameworks and a strong presence of key market players contribute to North America's anticipated dominance.
Region with highest CAGR:
Asia Pacific is poised for notable growth in the transdermal skin patches market owing to the region's expanding population, rising healthcare awareness and increasing prevalence of chronic diseases. Moreover, improving healthcare infrastructure, a shift towards non-invasive treatments, and the presence of emerging economies fostering healthcare advancements contribute to the projected substantial growth in Asia Pacific. Additionally, supportive government initiatives and a focus on enhancing healthcare accessibility further propel market expansion in this region.
Key players in the market
Some of the key players in transdermal skin patches market include 4P Therapeutics, AdhexPharma, Aveva Drug Delivery Systems, Bayer AG, Corium, LLC, GlaxoSmithKline (GSK), Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson, Luye Pharma Group, Mundipharma, Mylan N.V., Nitto Denko Corporation, Novartis, Pfizer Inc., Praj HiPurity Systems Limited, ProSolus Pharmaceuticals, Sorrento Therapeutics Inc, Teva Pharmaceuticals, TheraDep Technologies and Transdermal Delivery Solutions Corporation.
Key Developments:
In April 2023, researchers at MIT University developed a wearable patch that enables painless skin patch delivery. The patch utilizes painless ultrasonic waves to create tiny channels, allowing drugs to pass through the tough outer layer of the skin. This innovative approach holds the potential for delivering treatments for various skin conditions. This patch can also be adapted for delivering muscle relaxants, hormones, and other drugs.
In September 2022, Corium launched its Adlarity (donepezil transdermal system) for prescription use in the US Adlarity, a once-weekly patch, delivers consistent doses of donepezil through the skin. It could treat patients with mild, moderate, or severe dementia of Alzheimer’s type.
In April 2022, Luye Pharma Group announced that the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) had accepted the Marketing Authorization Application (MAA) for the company’s investigational Rivastigmine Twice Weekly Transdermal Patch that was indicated for treating Alzheimer's disease of mild to moderate symptoms.
Components Covered:
• Reservoir
• Drug-in-Adhesive
• Matrix
• Microneedle
• Other Components
Applications Covered:
• Pain Management
• Cardiovascular Disorders
• Central Nervous System Disorders
• Hormonal Therapy
• Neurological Disorders
• Nicotine Cessation
• Overactive Bladder
• Other Applications
Distribution Channels Covered:
• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Transdermal Skin Patches Market, By Component
5.1 Introduction
5.2 Reservoir
5.3 Drug-in-Adhesive
5.3.1 Single Layer
5.3.2 Multilayer
5.4 Matrix
5.5 Microneedle
5.6 Other Components
6 Global Transdermal Skin Patches Market, By Application
6.1 Introduction
6.2 Pain Management
6.3 Cardiovascular Disorders
6.4 Central Nervous System Disorders
6.5 Hormonal Therapy
6.6 Neurological Disorders
6.7 Nicotine Cessation
6.8 Overactive Bladder
6.9 Other Applications
7 Global Transdermal Skin Patches Market, By Distribution Channel
7.1 Introduction
7.2 Hospital Pharmacies
7.3 Online Pharmacies
7.4 Retail Pharmacies
8 Global Transdermal Skin Patches Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 4P Therapeutics
10.2 AdhexPharma
10.3 Aveva Drug Delivery Systems
10.4 Bayer AG
10.5 Corium, LLC
10.6 GlaxoSmithKline (GSK)
10.7 Hisamitsu Pharmaceutical Co., Inc.
10.8 Johnson & Johnson
10.9 Luye Pharma Group
10.10 Mundipharma
10.11 Mylan N.V.
10.12 Nitto Denko Corporation
10.13 Novartis
10.14 Pfizer Inc.
10.15 Praj HiPurity Systems Limited
10.16 ProSolus Pharmaceuticals
10.17 Sorrento Therapeutics Inc
10.18 Teva Pharmaceuticals
10.19 TheraDep Technologies
10.20 Transdermal Delivery Solutions Corporation
List of Tables
1 Global Transdermal Skin Patches Market Outlook, By Region (2021-2030) ($MN)
2 Global Transdermal Skin Patches Market Outlook, By Component (2021-2030) ($MN)
3 Global Transdermal Skin Patches Market Outlook, By Reservoir (2021-2030) ($MN)
4 Global Transdermal Skin Patches Market Outlook, By Drug-in-Adhesive (2021-2030) ($MN)
5 Global Transdermal Skin Patches Market Outlook, By Single Layer (2021-2030) ($MN)
6 Global Transdermal Skin Patches Market Outlook, By Multilayer (2021-2030) ($MN)
7 Global Transdermal Skin Patches Market Outlook, By Matrix (2021-2030) ($MN)
8 Global Transdermal Skin Patches Market Outlook, By Microneedle (2021-2030) ($MN)
9 Global Transdermal Skin Patches Market Outlook, By Other Components (2021-2030) ($MN)
10 Global Transdermal Skin Patches Market Outlook, By Application (2021-2030) ($MN)
11 Global Transdermal Skin Patches Market Outlook, By Pain Management (2021-2030) ($MN)
12 Global Transdermal Skin Patches Market Outlook, By Cardiovascular Disorders (2021-2030) ($MN)
13 Global Transdermal Skin Patches Market Outlook, By Central Nervous System Disorders (2021-2030) ($MN)
14 Global Transdermal Skin Patches Market Outlook, By Hormonal Therapy (2021-2030) ($MN)
15 Global Transdermal Skin Patches Market Outlook, By Neurological Disorders (2021-2030) ($MN)
16 Global Transdermal Skin Patches Market Outlook, By Nicotine Cessation (2021-2030) ($MN)
17 Global Transdermal Skin Patches Market Outlook, By Overactive Bladder (2021-2030) ($MN)
18 Global Transdermal Skin Patches Market Outlook, By Other Applications (2021-2030) ($MN)
19 Global Transdermal Skin Patches Market Outlook, By Distribution Channel (2021-2030) ($MN)
20 Global Transdermal Skin Patches Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
21 Global Transdermal Skin Patches Market Outlook, By Online Pharmacies (2021-2030) ($MN)
22 Global Transdermal Skin Patches Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
23 North America Transdermal Skin Patches Market Outlook, By Country (2021-2030) ($MN)
24 North America Transdermal Skin Patches Market Outlook, By Component (2021-2030) ($MN)
25 North America Transdermal Skin Patches Market Outlook, By Reservoir (2021-2030) ($MN)
26 North America Transdermal Skin Patches Market Outlook, By Drug-in-Adhesive (2021-2030) ($MN)
27 North America Transdermal Skin Patches Market Outlook, By Single Layer (2021-2030) ($MN)
28 North America Transdermal Skin Patches Market Outlook, By Multilayer (2021-2030) ($MN)
29 North America Transdermal Skin Patches Market Outlook, By Matrix (2021-2030) ($MN)
30 North America Transdermal Skin Patches Market Outlook, By Microneedle (2021-2030) ($MN)
31 North America Transdermal Skin Patches Market Outlook, By Other Components (2021-2030) ($MN)
32 North America Transdermal Skin Patches Market Outlook, By Application (2021-2030) ($MN)
33 North America Transdermal Skin Patches Market Outlook, By Pain Management (2021-2030) ($MN)
34 North America Transdermal Skin Patches Market Outlook, By Cardiovascular Disorders (2021-2030) ($MN)
35 North America Transdermal Skin Patches Market Outlook, By Central Nervous System Disorders (2021-2030) ($MN)
36 North America Transdermal Skin Patches Market Outlook, By Hormonal Therapy (2021-2030) ($MN)
37 North America Transdermal Skin Patches Market Outlook, By Neurological Disorders (2021-2030) ($MN)
38 North America Transdermal Skin Patches Market Outlook, By Nicotine Cessation (2021-2030) ($MN)
39 North America Transdermal Skin Patches Market Outlook, By Overactive Bladder (2021-2030) ($MN)
40 North America Transdermal Skin Patches Market Outlook, By Other Applications (2021-2030) ($MN)
41 North America Transdermal Skin Patches Market Outlook, By Distribution Channel (2021-2030) ($MN)
42 North America Transdermal Skin Patches Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
43 North America Transdermal Skin Patches Market Outlook, By Online Pharmacies (2021-2030) ($MN)
44 North America Transdermal Skin Patches Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
45 Europe Transdermal Skin Patches Market Outlook, By Country (2021-2030) ($MN)
46 Europe Transdermal Skin Patches Market Outlook, By Component (2021-2030) ($MN)
47 Europe Transdermal Skin Patches Market Outlook, By Reservoir (2021-2030) ($MN)
48 Europe Transdermal Skin Patches Market Outlook, By Drug-in-Adhesive (2021-2030) ($MN)
49 Europe Transdermal Skin Patches Market Outlook, By Single Layer (2021-2030) ($MN)
50 Europe Transdermal Skin Patches Market Outlook, By Multilayer (2021-2030) ($MN)
51 Europe Transdermal Skin Patches Market Outlook, By Matrix (2021-2030) ($MN)
52 Europe Transdermal Skin Patches Market Outlook, By Microneedle (2021-2030) ($MN)
53 Europe Transdermal Skin Patches Market Outlook, By Other Components (2021-2030) ($MN)
54 Europe Transdermal Skin Patches Market Outlook, By Application (2021-2030) ($MN)
55 Europe Transdermal Skin Patches Market Outlook, By Pain Management (2021-2030) ($MN)
56 Europe Transdermal Skin Patches Market Outlook, By Cardiovascular Disorders (2021-2030) ($MN)
57 Europe Transdermal Skin Patches Market Outlook, By Central Nervous System Disorders (2021-2030) ($MN)
58 Europe Transdermal Skin Patches Market Outlook, By Hormonal Therapy (2021-2030) ($MN)
59 Europe Transdermal Skin Patches Market Outlook, By Neurological Disorders (2021-2030) ($MN)
60 Europe Transdermal Skin Patches Market Outlook, By Nicotine Cessation (2021-2030) ($MN)
61 Europe Transdermal Skin Patches Market Outlook, By Overactive Bladder (2021-2030) ($MN)
62 Europe Transdermal Skin Patches Market Outlook, By Other Applications (2021-2030) ($MN)
63 Europe Transdermal Skin Patches Market Outlook, By Distribution Channel (2021-2030) ($MN)
64 Europe Transdermal Skin Patches Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
65 Europe Transdermal Skin Patches Market Outlook, By Online Pharmacies (2021-2030) ($MN)
66 Europe Transdermal Skin Patches Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
67 Asia Pacific Transdermal Skin Patches Market Outlook, By Country (2021-2030) ($MN)
68 Asia Pacific Transdermal Skin Patches Market Outlook, By Component (2021-2030) ($MN)
69 Asia Pacific Transdermal Skin Patches Market Outlook, By Reservoir (2021-2030) ($MN)
70 Asia Pacific Transdermal Skin Patches Market Outlook, By Drug-in-Adhesive (2021-2030) ($MN)
71 Asia Pacific Transdermal Skin Patches Market Outlook, By Single Layer (2021-2030) ($MN)
72 Asia Pacific Transdermal Skin Patches Market Outlook, By Multilayer (2021-2030) ($MN)
73 Asia Pacific Transdermal Skin Patches Market Outlook, By Matrix (2021-2030) ($MN)
74 Asia Pacific Transdermal Skin Patches Market Outlook, By Microneedle (2021-2030) ($MN)
75 Asia Pacific Transdermal Skin Patches Market Outlook, By Other Components (2021-2030) ($MN)
76 Asia Pacific Transdermal Skin Patches Market Outlook, By Application (2021-2030) ($MN)
77 Asia Pacific Transdermal Skin Patches Market Outlook, By Pain Management (2021-2030) ($MN)
78 Asia Pacific Transdermal Skin Patches Market Outlook, By Cardiovascular Disorders (2021-2030) ($MN)
79 Asia Pacific Transdermal Skin Patches Market Outlook, By Central Nervous System Disorders (2021-2030) ($MN)
80 Asia Pacific Transdermal Skin Patches Market Outlook, By Hormonal Therapy (2021-2030) ($MN)
81 Asia Pacific Transdermal Skin Patches Market Outlook, By Neurological Disorders (2021-2030) ($MN)
82 Asia Pacific Transdermal Skin Patches Market Outlook, By Nicotine Cessation (2021-2030) ($MN)
83 Asia Pacific Transdermal Skin Patches Market Outlook, By Overactive Bladder (2021-2030) ($MN)
84 Asia Pacific Transdermal Skin Patches Market Outlook, By Other Applications (2021-2030) ($MN)
85 Asia Pacific Transdermal Skin Patches Market Outlook, By Distribution Channel (2021-2030) ($MN)
86 Asia Pacific Transdermal Skin Patches Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
87 Asia Pacific Transdermal Skin Patches Market Outlook, By Online Pharmacies (2021-2030) ($MN)
88 Asia Pacific Transdermal Skin Patches Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
89 South America Transdermal Skin Patches Market Outlook, By Country (2021-2030) ($MN)
90 South America Transdermal Skin Patches Market Outlook, By Component (2021-2030) ($MN)
91 South America Transdermal Skin Patches Market Outlook, By Reservoir (2021-2030) ($MN)
92 South America Transdermal Skin Patches Market Outlook, By Drug-in-Adhesive (2021-2030) ($MN)
93 South America Transdermal Skin Patches Market Outlook, By Single Layer (2021-2030) ($MN)
94 South America Transdermal Skin Patches Market Outlook, By Multilayer (2021-2030) ($MN)
95 South America Transdermal Skin Patches Market Outlook, By Matrix (2021-2030) ($MN)
96 South America Transdermal Skin Patches Market Outlook, By Microneedle (2021-2030) ($MN)
97 South America Transdermal Skin Patches Market Outlook, By Other Components (2021-2030) ($MN)
98 South America Transdermal Skin Patches Market Outlook, By Application (2021-2030) ($MN)
99 South America Transdermal Skin Patches Market Outlook, By Pain Management (2021-2030) ($MN)
100 South America Transdermal Skin Patches Market Outlook, By Cardiovascular Disorders (2021-2030) ($MN)
101 South America Transdermal Skin Patches Market Outlook, By Central Nervous System Disorders (2021-2030) ($MN)
102 South America Transdermal Skin Patches Market Outlook, By Hormonal Therapy (2021-2030) ($MN)
103 South America Transdermal Skin Patches Market Outlook, By Neurological Disorders (2021-2030) ($MN)
104 South America Transdermal Skin Patches Market Outlook, By Nicotine Cessation (2021-2030) ($MN)
105 South America Transdermal Skin Patches Market Outlook, By Overactive Bladder (2021-2030) ($MN)
106 South America Transdermal Skin Patches Market Outlook, By Other Applications (2021-2030) ($MN)
107 South America Transdermal Skin Patches Market Outlook, By Distribution Channel (2021-2030) ($MN)
108 South America Transdermal Skin Patches Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
109 South America Transdermal Skin Patches Market Outlook, By Online Pharmacies (2021-2030) ($MN)
110 South America Transdermal Skin Patches Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
111 Middle East & Africa Transdermal Skin Patches Market Outlook, By Country (2021-2030) ($MN)
112 Middle East & Africa Transdermal Skin Patches Market Outlook, By Component (2021-2030) ($MN)
113 Middle East & Africa Transdermal Skin Patches Market Outlook, By Reservoir (2021-2030) ($MN)
114 Middle East & Africa Transdermal Skin Patches Market Outlook, By Drug-in-Adhesive (2021-2030) ($MN)
115 Middle East & Africa Transdermal Skin Patches Market Outlook, By Single Layer (2021-2030) ($MN)
116 Middle East & Africa Transdermal Skin Patches Market Outlook, By Multilayer (2021-2030) ($MN)
117 Middle East & Africa Transdermal Skin Patches Market Outlook, By Matrix (2021-2030) ($MN)
118 Middle East & Africa Transdermal Skin Patches Market Outlook, By Microneedle (2021-2030) ($MN)
119 Middle East & Africa Transdermal Skin Patches Market Outlook, By Other Components (2021-2030) ($MN)
120 Middle East & Africa Transdermal Skin Patches Market Outlook, By Application (2021-2030) ($MN)
121 Middle East & Africa Transdermal Skin Patches Market Outlook, By Pain Management (2021-2030) ($MN)
122 Middle East & Africa Transdermal Skin Patches Market Outlook, By Cardiovascular Disorders (2021-2030) ($MN)
123 Middle East & Africa Transdermal Skin Patches Market Outlook, By Central Nervous System Disorders (2021-2030) ($MN)
124 Middle East & Africa Transdermal Skin Patches Market Outlook, By Hormonal Therapy (2021-2030) ($MN)
125 Middle East & Africa Transdermal Skin Patches Market Outlook, By Neurological Disorders (2021-2030) ($MN)
126 Middle East & Africa Transdermal Skin Patches Market Outlook, By Nicotine Cessation (2021-2030) ($MN)
127 Middle East & Africa Transdermal Skin Patches Market Outlook, By Overactive Bladder (2021-2030) ($MN)
128 Middle East & Africa Transdermal Skin Patches Market Outlook, By Other Applications (2021-2030) ($MN)
129 Middle East & Africa Transdermal Skin Patches Market Outlook, By Distribution Channel (2021-2030) ($MN)
130 Middle East & Africa Transdermal Skin Patches Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
131 Middle East & Africa Transdermal Skin Patches Market Outlook, By Online Pharmacies (2021-2030) ($MN)
132 Middle East & Africa Transdermal Skin Patches Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
